Two New Drug Industry Lawsuits Challenge 340B Contract Pharmacy Access Laws in Kansas, Missouri

Drugmaker Novartis and trade organization PhRMA each recently filed a new lawsuit against separate state 340B contract pharmacy access laws.
A powerful brand name drug industry trade group has filed suit against a Kansas law prohibiting drugmaker 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: AstraZeneca Subpoenas in Arkansas, Mississippi; Minnesota AG’s Defense

Lawsuits challenging 340B contract pharmacy access laws recently heated up in Missouri, Mississippi and Maryland.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Third Drugmaker Sues Kansas Over Its 340B Contract Pharmacy Access Law

Novartis became the third pharmaceutical manufacturer to sue Kansas over its 340B contract pharmacy access law.
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Government, 340B Provider Groups Urge Appeals Court to Reverse Dismissal of Health System’s 340B Whistleblower Lawsuit

Adventist Health System/West's 340B whistleblower lawsuit received four amicus briefs in support of its appeal to the U.S. 9th Circuit Court of Appeals.
The U.S. government is urging a federal appeals court to dismiss a lower court’s “erroneous” decision to dismiss a California [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Maryland, Louisiana AGs Step Up Defense

Lawsuits challenging 340B contract pharmacy access laws recently heated up in Missouri, Mississippi and Maryland.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Petitions Supreme Court to Overturn Arkansas’ 340B Contract Pharmacy Access Law

PhRMA petitioned the U.S. Supreme Court to take a case on the constitutionality of Arkansas' 340B contract pharmacy access law.
A powerful drug industry trade group has asked the U.S. Supreme Court to overturn a federal appeals court’s decision to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Agrees to Send New York Times FOIA-Requested Documents 

Dept. of Health and Human Services exterior sign and building
HRSA will review and release some of the 340B-related records the New York Times is seeking through FOIA requests.
The federal agency tasked with overseeing the 340B program will review and release some of the 340B-related records the New [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Two Hospitals Sue HRSA to Block ‘Unlawfully Authorized’ Drugmaker 340B Program Audits

Oregon Health & Science University Hospital is one of two 340B hospitals to sue HRSA over approving a drugmaker audit. (Photo by M.O. Stevens)
Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Mississippi, Maryland and Arkansas Cases Heat Up

Federal district courts in Mississippi, Maryland and Arkansa recently saw various legal actions related to state 340B contract pharmacy access laws.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days After Legal Setback, Novartis Exempts Mississippi Providers From Contract Pharmacy Restrictions

Novartis exempted Mississippi 340B providers from its contract pharmacy restrictions following a new state law.
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live